Irving Kahn - Kahn Brothers Group
Holding/activity history for Gsk Plc (AP47)
← All AP47 superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | 0 | 0.00 | Sell 100.00% | 6.45 | SEC | ||
| 2025 Q1 | 822,227 | 6.45 | Reduce 7.06% | 0.01 | $38.74 | $31,852,636 | SEC |
| 2024 Q4 | 884,708 | 0.15 | Reduce 16.44% | 1.23 | $33.82 | $29,921,125 | SEC |
| 2024 Q3 | 1,058,832 | 7.46 | Reduce 14.70% | 1.18 | $40.88 | $43,285,078 | SEC |
| 2024 Q2 | 1,241,261 | 8.04 | Reduce 0.99% | 0.08 | $38.50 | $47,788,450 | SEC |
| 2024 Q1 | 1,253,644 | 7.98 | Reduce 0.46% | 0.03 | $42.87 | $53,743,386 | SEC |
| 2023 Q4 | 1,259,482 | 7.36 | Reduce 1.78% | 0.13 | $37.06 | $46,676,538 | SEC |
| 2023 Q3 | 1,282,289 | 7.26 | Add 1.49% | 0.11 | $36.25 | $46,483,403 | SEC |
| 2023 Q2 | 1,263,458 | 6.61 | Reduce 1.10% | 0.07 | $35.64 | $45,029,371 | SEC |
| 2023 Q1 | 1,277,476 | 6.55 | Add 4.12% | 0.26 | $35.58 | $45,453,031 | SEC |
| 2022 Q4 | 1,226,906 | 5.68 | Reduce 5.98% | 0.36 | $35.14 | $43,113,031 | SEC |
| 2022 Q3 | 1,304,939 | 5.99 | Reduce 8.82% | 0.74 | $29.43 | $38,404,190 | SEC |
| 2022 Q2 | 1,431,160 | 8.39 | Add 0.32% | 0.03 | $43.53 | $62,297,972 | SEC |
| 2022 Q1 | 1,426,664 | 7.90 | Reduce 0.83% | 0.07 | $43.56 | $62,145,788 | SEC |
| 2021 Q4 | 1,438,569 | 9.01 | Add 6.30% | 0.53 | $44.10 | $63,440,893 | SEC |
| 2021 Q3 | 1,353,358 | 7.52 | Add 4.34% | 0.31 | $38.21 | $51,711,809 | SEC |
| 2021 Q2 | 1,297,109 | 7.63 | Add 2.48% | 0.18 | $39.82 | $51,650,880 | SEC |
| 2021 Q1 | 1,265,770 | 7.15 | Reduce 1.26% | 0.10 | $35.69 | $45,175,331 | SEC |
| 2020 Q4 | 1,281,924 | 8.28 | Reduce 8.87% | 0.90 | $36.80 | $47,174,803 | SEC |
| 2020 Q3 | 1,406,689 | 10.20 | Reduce 7.33% | 0.78 | $37.64 | $52,947,774 | SEC |
| 2020 Q2 | 1,517,918 | 10.67 | Reduce 1.66% | 0.18 | $40.98 | $62,201,405 | SEC |
| 2020 Q1 | 1,543,618 | 10.80 | Reduce 2.77% | 0.25 | $37.89 | $58,487,686 | SEC |
| 2019 Q4 | 1,587,628 | 9.15 | Reduce 2.03% | 0.18 | $46.99 | $74,603,639 | SEC |
| 2019 Q3 | 1,620,599 | 8.80 | Add 0.97% | 0.08 | $42.68 | $69,167,165 | SEC |
| 2019 Q2 | 1,605,014 | 8.16 | Add 25.73% | 1.67 | $40.02 | $64,232,661 | SEC |
| 2019 Q1 | 1,276,550 | 8.44 | Add 1.24% | 0.10 | $41.79 | $53,347,024 | SEC |
| 2018 Q4 | 1,260,940 | 8.79 | Add 1.56% | 0.14 | $38.21 | $48,180,518 | SEC |
| 2018 Q3 | 1,241,516 | 7.73 | Add 0.40% | 0.03 | $40.17 | $49,871,697 | SEC |
| 2018 Q2 | 1,236,592 | 8.01 | Add 0.48% | 0.04 | $40.31 | $49,847,023 | SEC |
| 2018 Q1 | 1,230,642 | 7.74 | Add 8.03% | 0.58 | $39.07 | $48,081,183 | SEC |
| 2017 Q4 | 1,139,163 | 6.44 | Add 11.56% | 0.67 | $35.47 | $40,406,111 | SEC |
| 2017 Q3 | 1,021,135 | 6.44 | Reduce 3.22% | 0.23 | $40.60 | $41,458,081 | SEC |
| 2017 Q2 | 1,055,085 | 7.06 | Add 0.39% | 0.03 | $43.12 | $45,495,265 | SEC |
| 2017 Q1 | 1,050,995 | 7.74 | Add 26.12% | 1.60 | $42.16 | $44,309,950 | SEC |
| 2016 Q4 | 833,315 | 5.53 | Buy | 5.53 | $38.51 | $32,090,960 | SEC |